The abstract is read at the publisher; the summary is JClub's.
An engineered probiotic in mice performs logic computation on four stage-specific inflammatory biomarkers and, with a CRISPR molecular recorder, enables precise diagnosis and closed-loop colitis treatment.
- Why it matters: IBD involves multiple, changing biomarkers, but therapeutic microbes have limited ability to process them for intelligent, site-specific diagnosis and monitoring in the gut.
- What they did: The system integrates four biomarker-responsive stages with a CRISPR-based molecular recorder that tracks biomarker dynamics and turns inflammatory signals into quantifiable, site-specific base-editing events.
- The result: A multimodal machine-learning classifier using bioluminescent reporter signals and sequencing data stages intestinal inflammation with accuracy 0.83 ± 0.05, enabling analysis of disease progression in vivo.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.